Nemaria, Kingston Lyster P.

HRN: 21-81-12  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2025
CEFUROXIME 1.5GM (VIAL)
07/09/2025
07/16/2025
IV
500mg
Q8hours
ARTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  URTI    Compliance to guidelines: